Real-World Evidence of Adjuvant Immunotherapy in Resected Stage III and IV Melanoma Patients: CADIM Trial Final Results. Experience From 2 Tertiary Referral Centers M. Morellá Fernández, J. Balsalobre Yago, J. Martínez García, M. Peláez Gutiérrez, A. López Muñoz, A.I. Silvestre Ballesta, B. Sánchez Lafuente, I. Martínez Martín, P. Cerezuela Fuentes

Multicenter, Prospective, Case–Control Study of Exposome in Melanoma A. Navarro-Bielsa, T. Gracia-Cazaña, M. Almagro, S. De-la-Fuente-Meira, Á. Florez, O. Yélamos, T. Montero-Vilchez, C. González-Cruz, A. Diago, I. Abadías-Granado, V. Fuentelsaz, M. Colmenero, J. Bañuls, S. Arias-Santiago, A. Buendía-Eisman, M. Almenara-Blasco, P. Gil-Pallares, Y. Gilaberte

Multicenter Analysis of the Surgical Management and Adjuvant Therapy of Patients With Melanoma and a Positive Sentinel Lymph Node Biopsy E. Samaniego-González, S. Podlipnik, S. Ribero, E. Nagore, A. Boada, J. Cañueto, S. Paradela, B. de Unamuno, P. Rodríguez-Jiménez, S. Puig, J. Malvehy, C. Carrera, G. Roccuzzo, C. Requena, E. Manrique-Silva, N. Richarz, A. Ruiz-Villanueva, V. Traves, S. España-Fernández, R. Botella-Estrada, M.A. González-Morán, A. Tejera-Vaquerizo